依达拉奉联合尤瑞克林治疗急性脑梗死的临床效果观察

张晓勋

（陕西省宝鸡市陈仓医院神经内科，陕西 宝鸡，721000）

浏览次数：264次 下载次数：504次

摘要：

目的 研究依达拉奉联合尤瑞克林治疗急性脑梗死的临床效果。方法 选取本院2015年1月至2016年7月收治的80例急性脑梗死患者，随机分为对照组和观察组，各40 例。对照组给予依达拉奉治疗，观察组在此基础上给予尤瑞克林治疗。 比较分析两组患者治疗前、后NIHSS评分的变化情况及临床疗效。结果 治疗前，两组患者的NIHSS 评分比较，差异不显 著（P>0.05）；通过不同的方式治疗后，两组患者的NIHSS 评分均降低，且观察组的NIHSS评分明显低于对照组，差异具 有统计学意义（P<0.05）。通过不同的方式治疗后，观察组患者治疗有效率为92.50%（37/40），明显高于对照组的70.00%（28/40），差异具有统计学意义（P<0.05）。结论 依达拉奉联合尤瑞克林能够显著改善急性脑梗塞患者神经功能缺损状态，疗效显著，值得临床推广应用。

关键词：依达拉奉；尤瑞克林；急性脑梗死

中图分类号：R743.3文献标志码：A文章编号：2096-1413(2017)34-0055-02

Clinical curative effect observation of edaravone combined with urinary kallidinogenase in patients with acute cerebral infarction
ZHANG Xiao-xun
(Neurology Department, Baoji Chencang Hospital, Baoji 721000, China)

ABSTRACT: Objective To study the clinical curative effect of edaravone combined with urinary kallidinogenase in patients with acute cerebral infarction. Methods A total of 80 patients with acute cerebral infarction admitted in our hospital from January 2015 to July 2016 were selected and randomly divided into experimental group and control group, with 40 cases in each group. The control group was given edaravone, while the experimental group was treated with urinary kallidinogenase on the basis of the control group. The NIHSS score before and after treatment and clinical effects were compared between the two groups. Results Before treatment, there were no significant differences of NIHSS scores in the two groups (P>0.05). After the different treatment, the NIHSS scores in the two groups significantly decreased, and the NIHSS score in the experimental group was obviously lower than that in the control group, and the difference was statistically significant (P<0.05). After the different treatment, the effective rate of treatment in the experimental group was 92.50%, which was obviously higher than 70.00% in the control group, and the difference was statistically significant (P<0.05). Conclusion Edaravone combined with urinary kallidinogenase for the treatment of patients with acute cerebral infarction can improve the status of neurological function impairment and has well clinical effect, which is worthy of promotion and application in clinic.
KEYWORDS: edaravone; urinary kallidinogenase; acute cerebral infarction

参考文献：
[1] 蔡同甲.尤瑞克林联合依达拉奉治疗急性脑梗死的疗效观察[J].中 西医结合心脑血管病杂志,2011,9(11):1328-1329.
[2] 刘旭,何志义.尤瑞克林联合依达拉奉治疗急性脑梗死的Meta 分 析[J].实用药物与临床,2012,15(6):329-331.
[3] 刘向红,钟振洲,肖小六.尤瑞克林联合依达拉奉治疗急性脑梗塞 的临床观察[J].医学信息(旬刊),2010,5(5):1244-1245.
[4] 李金星.尤瑞克林联合依达拉奉治疗急性脑梗死的临床疗效观察 [J].中国医药指南,2016,14(12):101.
[5] 翟继红,郭文龙,李永超,等.注射用尤瑞克林联合依达拉奉治疗基 底动脉尖综合征的近期疗效观察[J].中西医结合心脑血管病杂志,2016,14(5):559-560.
[6] 李颖,杜晓红,赵晓薇,等.注射用尤瑞克林联合依达拉奉治疗急性 脑梗死的临床观察[J].中国医师进修杂志,2009,32(19):1-2.
[7] 李皓亮,魏桂荣.依达拉奉联合单唾液酸四己糖神经节苷脂钠治疗 急性脑梗死的临床研究[J].中国社区医师:医学专业,2012,14(16):53-54.
[8] 李天杰.奥扎格雷钠联合依达拉奉治疗急性脑梗死疗效观察[J].中 国实用神经疾病杂志,2011,6(21):56-57.
[9] 黄志强.尤瑞克林联合依达拉奉治疗急性脑梗死临床疗效观察[J]. 中国现代药物应用,2015,11(2):138-139.
[10] 李碧波,何厚华.重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓早 期治疗急性脑梗死的疗效[J].中外医疗,2011,30(5):1-2.
[11] 朱远群,谭双全.依达拉奉联合尤瑞克林治疗进展性脑梗死44 例 [J].实用医学杂志,2011,27(1):104-105.
[12] 何琼,伍有权.依达拉奉联合尤瑞克林治疗急性脑梗塞的疗效观 察[J].现代生物医学进展,2010,10(24):4733-4734.
[13] 党利华,邹晓辉,王咏龙.依达拉奉联合尤瑞克林治疗急性脑梗死 的疗效观察[J].中国热带医学,2010,10(6):746-747.
[14] 刘振宇,王丽华,周俊英,等.依达拉奉联合尤瑞克林治疗对急性脑 梗死患者血液流变学及血管内皮细胞功能的影响[J].海南医学院学 报,2014,20(3):337-339,343.
[15] 王彦君.依达拉奉和尤瑞克林联合治疗53 例急性脑梗死的疗效 及其对血液流变学和血管内皮细胞功能的影响[J].中国医药科学,2015,5(17):101-103.